Skip to main content

Advertisement

Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas

Fig. 3

Effect of trabectedin (Et-743) and rucaparib combination on apoptosis a Annexin V FITC-A vs propidium iodide-A plots from the gated cells shows the populations corresponding to viable and non-apoptotic (Annexin V–PI–), early (Annexin V + PI–), and late (Annexin V + PI+) apoptotic cells in IB111 cell line. b Quantification of apoptotic cells after 72 h of treatment with trabectedin or rucaparib alone or combination of the two drugs

Back to article page